A team of researchers from Algorithmiq, IBM, and the Cleveland Clinic has won a $2-million Quantum for Bio prize for their work on light-sensitive cancer drugs, which could be activated by light to target tumors more precisely and reduce toxicity. They used a hybrid approach combining quantum and classical computing to simulate how these drugs interact with light, aiming to improve their effectiveness. Although current quantum computers can’t fully handle these complex simulations, the team’s work shows promise for future quantum systems to provide insights unattainable by classical methods. This research could also extend to other areas, like designing new antimicrobial drugs. The competition, backed by Wellcome Leap, encouraged teams to develop algorithms for biological applications, preparing for when quantum hardware advances.
QUESTION: How might advancements in quantum computing change the way we approach medical treatments in the future?
Quantum computers take on health care: light-sensitive cancer drugs win US$2 million contest
